
Growth Factor
Ipamorelin5mg
In Stock
€44.95
CJC-1295 is a growth hormone releasing hormone analogue studied in endocrine signalling research.

CJC-1295 is a modified GHRH analogue available with and without a drug affinity complex, studied in secretagogue research.
Supplied as a lyophilised powder for laboratory research use only.
GHRH receptor research
Receptor binding and signalling studies.
Secretagogue pathways
Pulsatile release research in models.
Half-life extension
Affinity complex chemistry research.
Combination research
Studied alongside secretagogues such as Ipamorelin.
What is CJC-1295?
An introduction to CJC-1295: sequence class, how it is supplied and where it appears in the research literature.
In preparationCJC-1295 Research
A directory of laboratory research areas in which CJC-1295 has been studied.
In preparationCJC-1295 Mechanism of Action
Receptor interaction and signalling pathways investigated in CJC-1295 research.
In preparationCJC-1295 Stability and Storage
Handling, reconstitution and storage considerations reported for CJC-1295 in laboratory settings.
In preparation
Growth Factor
Ipamorelin5mg
In Stock
€44.95

Growth Factor
Sermorelin5mg
In Stock
€34.95

Growth Factor
Tesamorelin5mg
In Stock
€69.95
References and further reading are listed within each article. Analytical documentation for the material we supply is published in our Certificates of Analysis library, and every compound in this class is listed under Growth Factor Research Peptides. All products are supplied for laboratory research use only.